Literature DB >> 12967310

Synthesis of an oxazoline analogue of apratoxin A.

Bin Zou1, Jingjun Wei, Guorong Cai, Dawei Ma.   

Abstract

[structure: see text] Michael addition of Me(2)Cu(CN)Li(2) to alpha,beta-unsaturated lactone 7 derived from beta-hydroxyl ketone 5 provides lactone 8, which is converted to alcohol 11 using Oppolzer's methodology as the key step. Connection of 11 with the l-proline moiety and subsequent installation of an oxazoline ring affords 16, which is coupled with tripeptide 21; subsequent macrocyclization then furnishes 4, an oxazoline analogue of apratoxin A.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12967310     DOI: 10.1021/ol035332y

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  5 in total

1.  Evolved diversification of a modular natural product pathway: apratoxins F and G, two cytotoxic cyclic depsipeptides from a Palmyra collection of Lyngbya bouillonii.

Authors:  Kevin Tidgewell; Niclas Engene; Tara Byrum; Joseph Media; Takayuki Doi; Fred A Valeriote; William H Gerwick
Journal:  Chembiochem       Date:  2010-07-05       Impact factor: 3.164

2.  Total synthesis of the marine cyanobacterial cyclodepsipeptide apratoxin A.

Authors:  Jiehao Chen; Craig J Forsyth
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-01       Impact factor: 11.205

3.  Apratoxin S10, a Dual Inhibitor of Angiogenesis and Cancer Cell Growth To Treat Highly Vascularized Tumors.

Authors:  Weijing Cai; Qi-Yin Chen; Long H Dang; Hendrik Luesch
Journal:  ACS Med Chem Lett       Date:  2017-09-18       Impact factor: 4.345

Review 4.  Synthesis of novel cyclopeptides containing heterocyclic skeletons.

Authors:  Fatima Hamdan; Fatemeh Tahoori; Saeed Balalaie
Journal:  RSC Adv       Date:  2018-10-03       Impact factor: 4.036

5.  Improved total synthesis and biological evaluation of potent apratoxin S4 based anticancer agents with differential stability and further enhanced activity.

Authors:  Qi-Yin Chen; Yanxia Liu; Weijing Cai; Hendrik Luesch
Journal:  J Med Chem       Date:  2014-03-24       Impact factor: 7.446

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.